Literature DB >> 3376123

The pattern of pyridoxine-induced lesion: difference between the high and the low toxic level.

G J Krinke1, R E Fitzgerald.   

Abstract

A fundamental prerequisite for the design of neurotoxicological safety studies is the determination of the target areas in the nervous system which are specific for particular kinds of toxicants. The target areas should be identified in special "lesion-pattern-finding" experiments. The pyridoxine-induced lesion is a prototype of the pattern characteristic of a peripheral, primary sensory neuropathy. Depending on the conditions of treatment such as the dosage level and the timing of examination, the structural changes may be more obvious either in the proximal or the distal portion of the neuron, while the functional signs may vary from severe sensory paralysis to quite unremarkable behavior.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3376123     DOI: 10.1016/0300-483x(88)90190-4

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  8 in total

Review 1.  Animal models of peripheral neuropathy due to environmental toxicants.

Authors:  Deepa B Rao; Bernard S Jortner; Robert C Sills
Journal:  ILAR J       Date:  2014

2.  Differential effects of orally versus parenterally administered qinghaosu derivative artemether in dogs.

Authors:  W Classen; B Altmann; P Gretener; C Souppart; P Skelton-Stroud; G Krinke
Journal:  Exp Toxicol Pathol       Date:  1999-11

3.  Evidence of GLP-1-mediated neuroprotection in an animal model of pyridoxine-induced peripheral sensory neuropathy.

Authors:  TracyAnn Perry; Harold W Holloway; Ananda Weerasuriya; Peter R Mouton; Kara Duffy; Julie A Mattison; Nigel H Greig
Journal:  Exp Neurol       Date:  2006-11-22       Impact factor: 5.330

4.  Proprioceptive neuropathy affects normalization of the H-reflex by exercise after spinal cord injury.

Authors:  Karen Ollivier-Lanvin; Benjamin E Keeler; Rachel Siegfried; John D Houlé; Michel A Lemay
Journal:  Exp Neurol       Date:  2009-11-11       Impact factor: 5.330

5.  SP, CGRP changes in pyridoxine induced neuropathic dogs with nerve growth factor gene therapy.

Authors:  Joo-Yeon Kang; Dae Young Yoo; Kwon-Young Lee; Wooseok Im; Manho Kim; Jung Hoon Choi; Hwa-Young Youn; Sae Hoon Kim; In Koo Hwang; Jin-Young Chung
Journal:  BMC Neurosci       Date:  2016-01-05       Impact factor: 3.288

6.  Blood Neurofilament Light Chain as a Potential Biomarker for Central and Peripheral Nervous Toxicity in Rats.

Authors:  Tomoya Sano; Yasushi Masuda; Hironobu Yasuno; Tadahiro Shinozawa; Takeshi Watanabe; Masaaki Kakehi
Journal:  Toxicol Sci       Date:  2021-12-28       Impact factor: 4.849

7.  Pyridoxine induced neuropathy by subcutaneous administration in dogs.

Authors:  Jin-Young Chung; Jung-Hoon Choi; Cheol-Yong Hwang; Hwa-Young Youn
Journal:  J Vet Sci       Date:  2008-06       Impact factor: 1.672

8.  Neuropathological changes in dorsal root ganglia induced by pyridoxine in dogs.

Authors:  Sumin Yun; Woosuk Kim; Min Soo Kang; Tae Hyeong Kim; Yoonhwan Kim; Jin-Ok Ahn; Jung Hoon Choi; In Koo Hwang; Jin-Young Chung
Journal:  BMC Neurosci       Date:  2020-03-24       Impact factor: 3.288

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.